Primary and secondary glioblastomas appeared to bear mutually exclusive gene alterations, like epidermal growth factor receptor (EGFR) overexpression and tumor protein P53 (TP53) mutations, reflecting two distinct tumor entities with different biological behavior and clinical prognosis [7]. The gene discussed is EGFR; the disease is neoplasm.